1. Home
  2. COEP vs EBON Comparison

COEP vs EBON Comparison

Compare COEP & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • EBON
  • Stock Information
  • Founded
  • COEP 2017
  • EBON 2010
  • Country
  • COEP United States
  • EBON China
  • Employees
  • COEP N/A
  • EBON N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • EBON Semiconductors
  • Sector
  • COEP Health Care
  • EBON Technology
  • Exchange
  • COEP Nasdaq
  • EBON Nasdaq
  • Market Cap
  • COEP 27.4M
  • EBON 25.3M
  • IPO Year
  • COEP N/A
  • EBON 2020
  • Fundamental
  • Price
  • COEP $10.77
  • EBON $4.03
  • Analyst Decision
  • COEP
  • EBON
  • Analyst Count
  • COEP 0
  • EBON 0
  • Target Price
  • COEP N/A
  • EBON N/A
  • AVG Volume (30 Days)
  • COEP 56.9K
  • EBON 36.7K
  • Earning Date
  • COEP 08-15-2025
  • EBON 08-22-2025
  • Dividend Yield
  • COEP N/A
  • EBON N/A
  • EPS Growth
  • COEP N/A
  • EBON N/A
  • EPS
  • COEP N/A
  • EBON N/A
  • Revenue
  • COEP $62,874.00
  • EBON $5,868,771.00
  • Revenue This Year
  • COEP N/A
  • EBON N/A
  • Revenue Next Year
  • COEP N/A
  • EBON N/A
  • P/E Ratio
  • COEP N/A
  • EBON N/A
  • Revenue Growth
  • COEP N/A
  • EBON 20.88
  • 52 Week Low
  • COEP $2.31
  • EBON $3.00
  • 52 Week High
  • COEP $13.70
  • EBON $10.94
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.53
  • EBON 51.94
  • Support Level
  • COEP $11.30
  • EBON $4.25
  • Resistance Level
  • COEP $12.71
  • EBON $5.10
  • Average True Range (ATR)
  • COEP 0.89
  • EBON 0.39
  • MACD
  • COEP 0.18
  • EBON -0.04
  • Stochastic Oscillator
  • COEP 54.39
  • EBON 49.36

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

Share on Social Networks: